NEOCURA

Welcome to the Brand page for “NEOCURA”, which is offered here for Diagnostic test kits for scientific use comprising reagents for medical use, slides, solid matrix materials, microfluidic devices and instruction manuals;diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents for scientific use, slides, solid matrix materials, microfluidic devices and instruction manuals;providing medical services including diagnosis, treatment, and care management in fields of oncology, pulmonology, hematology, pathology, immunology, and medical genetics; performing medical testing on tissue samples and body fluids for the detection of genetic and genomic information pertaining to human disease for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes of oncology, pulmonology, hematology, pathology, immunology, and medical genetics;diagnostic kits comprising medical instruments for measuring, testing, and analyzing blood, bodily fluids, and tissue;conducting medical research and providing technical support in the nature of computer software support services to other medical researchers in the fields of oncology, pulmonology, hematology, pathology, and medical genetics; conducting clinical trials and supporting other medical and biomedical researchers by providing medical and scientific research in clinical trials in the fields of oncology, pulmonology, hematology, pathology, immunology, and medical genetics; providing software as a service (saas)services featuring software for use in medical diagnostics using bioinformatics analysis supporting clinicians and researchers in the fields of oncology, pulmonology, hematology, pathology, immunology, and medical genetics; providing software as a service (saas) services featuring software for the analysis of clinical laboratory data, genomics data, and environmental factor data for use in identifying and predicting actionable biomarkers, neoantigens, other molecular data relevant to developing paired diagnostics and therapeutics in the fields of oncology, pulmonology, hematology, pathology, immunology, and medical genetics; providing software as a service (saas) services featuring software for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models for utilizing said trained data models for use in biomedical research; providing software as a service (saas) services featuring software for detecting and predicting significance of neoantigens and peptides on cells relevant to immunotherapy development; providing medical laboratory services and performing medical testing on tissue samples and body fluids for the detection of genetic and genomic information pertaining to human disease for medical research purposes;.

Its status is currently believed to be active. Its class is unavailable. “NEOCURA” is believed to be currently owned by “CuraCloud Corporation”.